Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers

Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications

(2009) Jin-Qiang Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Estrogen Receptor β as a Mitochondrial Vulnerability Factor

(2009) Shao-Hua Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore

(2008) Anna W.C. Leung et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers

(2008) Maria M Litwiniuk et al.   BMC CANCER

Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients

(2008) A. M. Shaaban et al.   CLINICAL CANCER RESEARCH

Triple-Negative Breast Cancer: Risk Factors to Potential Targets

(2008) B. P. Schneider et al.   CLINICAL CANCER RESEARCH

Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy

(2008) Naoko Honma et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen actions on mitochondria—Physiological and pathological implications

(2008) James W. Simpkins et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

ERβ in breast cancer—Onlooker, passive player, or active protector?

(2008) Emily M. Fox et al.   STEROIDS